Abstract
Solid tumors with areas of low oxygen tension (hypoxia) have a poor prognosis, as cells in this environment often survive radiation and chemotherapy. In this report we describe how this hypoxic environment can be used to activate heterologous gene expression driven by a hypoxia-responsive element (HRE), which interacts with the transcriptional complex hypoxia-inducible factor-1 (HIF-1). Our results demonstrate that the HIF-1/HRE system of gene regulation is active in hypoxic tumor cells and show the potential of exploiting tumor-specific conditions for the targeted expression of diagnostic or therapeutic genes in cancer therapy.
MeSH Terms
Animals
Antimetabolites, Antineoplastic/pharmacology
Cell Hypoxia
Cytosine Deaminase
DNA-Binding Proteins/physiology
Fibrosarcoma/genetics,metabolism
Flucytosine/pharmacology
Fluorouracil/pharmacology
Gene Expression Regulation, Neoplastic/drug effects,genetics
Genes, Reporter/genetics
Humans
Hypoxia-Inducible Factor 1
Hypoxia-Inducible Factor 1, alpha Subunit
Mice
Mice, Nude
Misonidazole/analogs & derivatives,pharmacology
Neoplasm Transplantation
Nuclear Proteins/physiology
Nucleoside Deaminases/genetics
Oxygen/pharmacology
Phosphoglycerate Kinase/genetics
Prodrugs/pharmacology
Promoter Regions, Genetic/genetics
Recombinant Fusion Proteins/biosynthesis
Transcription Factors
Tumor Cells, Cultured
Chemicals
Antimetabolites, Antineoplastic
DNA-Binding Proteins
HIF1A protein, human
Hif1a protein, mouse
Hypoxia-Inducible Factor 1
Hypoxia-Inducible Factor 1, alpha Subunit
Nuclear Proteins
Prodrugs
Recombinant Fusion Proteins
Transcription Factors
1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol
Misonidazole
Flucytosine
Phosphoglycerate Kinase
Nucleoside Deaminases
Cytosine Deaminase
Oxygen
Fluorouracil
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Dachs G U
Experimental Oncology Division, Medical Research Council, Harwell, UK.
Patterson A V
Firth J D
Ratcliffe P J
Townsend K M
Stratford I J
Harris A L